Showing results (161-170 of 326) with videos related to
Sort By:
Pageof 33
Journal of Neuro-Oncology|January 25, 2014
Towards optimizing the sequence of bevacizumab and nitrosoureas in recurrent malignant gliomaBenedikt Wiestler, Alexander Radbruch, Matthias Osswald, et al.Nature Reviews. Neurology|June 11, 2014
MGMT testing--the challenges for biomarker-based glioma treatmentWolfgang Wick, Michael Weller, Martin van den Bent, et al.Stroke|June 10, 2020
Acute Stroke in Times of the COVID-19 Pandemic: A Multicenter StudyCarolin Hoyer, Anne Ebert, Hagen B Huttner, et al.European Radiology|September 22, 2021
Association of iron rim lesions with brain and cervical cord volume in relapsing multiple sclerosisClaudia E Weber, Julia Krämer, Matthias Wittayer, et al.Stem Cells and Development|November 6, 2009
Mouse mesenchymal stem cells suppress antigen-specific TH cell immunity independent of indoleamine 2,3-dioxygenase 1 (IDO1)Tobias V Lanz, Christiane A Opitz, Peggy P Ho, et al.Multiple Sclerosis and Related Disorders|January 23, 2019
Temporal evolution of acute multiple sclerosis lesions on serial sodium (23Na) MRIPhilipp Eisele, Simon Konstandin, Kristina Szabo, et al.Nature Communications|February 20, 2020
Heterogeneity of response to immune checkpoint blockade in hypermutated experimental gliomasKatrin Aslan, Verena Turco, Jens Blobner, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 15, 2011
Costimulatory protein 4IgB7H3 drives the malignant phenotype of glioblastoma by mediating immune escape and invasivenessDieter Lemke, Philipp-Niclas Pfenning, Felix Sahm, et al.Frontiers in Immunology|June 2, 2020
Constitutive Expression of the Immunosuppressive Tryptophan Dioxygenase TDO2 in Glioblastoma Is Driven by the Transcription Factor C/EBPβTakumi Kudo, Mirja T Prentzell, Soumya R Mohapatra, et al.Neuro-Oncology|August 6, 2013
Enzastaurin before and concomitant with radiation therapy, followed by enzastaurin maintenance therapy, in patients with newly diagnosed glioblastoma without MGMT promoter hypermethylationWolfgang Wick, Joachim P Steinbach, Michael Platten, et al.Pageof 33